Crystals of phage P1 Doc are grown in its free state, in complex with a 22 amino acid C-terminal peptide of Phd and in complex with full length Phd.
Introduction
Toxin-antitoxin (TA) modules are a class of operons widespread in free living and opportunistic pathogenic procaryotes (Pandey & Gerdes, 2005) . They are involved in regulating the pace of metabolism and may induce a state of dormancy in case of nutritional stress (Pedersen et al., 2002 . In a few cases a link between TA modules and persister cell formation have been found (Keren et al., 2004; Lewis, 2005) . Under certain conditions, ectopic overexpression of TA modules may lead to cell death (Amitai et al., 2004; Engelberg-Kulka et al., 2006) , although this notion has been contested (Pedersen et al., 2002 , and high level protein prodution after induction of TA proteins remains possible from mRNA's lacking a cleavage site for the RNase toxin (Suzuki et al., 2005) . On plasmids TA modules act as addiction systems aiding plasmid maintenance in the bacterial population (Gerdes et al., 1986) . Related effects have been observed for chromosome-located TA systems as some of them have been shown to diminish large-scale genome reductions in the absence of selection (Szekeres et al., 2007) . 2 TA modules have been categorized into a number of families based upon sequence similarities between their respective toxins and antitoxins (Pandey & Gerdes, 2005; Anantharaman & Aravind, 2003) . Where investigated, the toxins have been shown to be mRNA-cleaving RNases (Christensen & Gerdes, 2003a,b; Pedersen et al., 2003; : Kamada & Hanaoka, 2005 , non-enzymatic ribosome inhibitors (Liu et al., 2008) or to poison gyrase (Bernard & Couturier, 1992; Jiang et al., 2002) . Structural studies identified several different toxin folds (Loris et al., 1999; Hagreaves et al., 2002; Takagi et al., 2005; Kamada & Hanaoka, 2005; Mattison et al., 2006) . Among the best known ones is a microbial ribonuclease fold that is found in mRNA interferases such as RelE, YoeB and HigB but also in the gyrase poison ParE. Similarly, the MazF mRNA interferase family and the gyrase poison CcdB share a common fold (Hargreaves et al., 2002; Buts et al., 2005) . All antitoxins show a modular structure (Loris et al., 2003; Kamada et al., 2003; Madl et al., 2006; Mattison et al., 2006; Oberer et al., 2007; Li et al., 2008) in agreement with genetics that pinpoints DNA binding activity at their N-terminal region and toxin neutralizing activity at their Cterminal region (Smith & Magnuson, 2004; McKinley & Magnuson, 2005; Madl et al., 2006; .
Recent genetic evidence also suggests that toxins belonging to one family may be associated with different antitoxin DNA-binding domains (Fico & Mahillon, 2006) , complicating the genetic relationships between different families of TA modules.
The phd/doc operon forms a relatively small family of TA modules, the first member of which was identified on bacteriophage P1 where it stabilizes the prophage in its plasmidic form (Lehnherr et al., 1993) . Like other TA modules, phd/doc encodes a toxin (Doc) preceded by an antitoxin (Phd). The members of the Phd protein family show weak sequence identity to the YefM family of antitoxins (Anantharaman & Aravind, 2003; Kamada & Hanaoka, 2005) . The N-terminal domain of Phd is a DNA binding domain essential for autoregulation, although efficient repression also requires the presence of Doc (Magnuson et al., 1996; Magnuson & Yarmolinsky, 1998; Gazit & Sauer, 1999a) . The C-terminal domain of the protein is responsible for counteracting Doc (Smith & Magnuson, 2004; McKinley & Magnuson, 2005) .
ClpXP-mediated degradation of Phd upon plasmid loss activates Doc (Lehnherr & Yarmolinsky, 1995) . Doc interferes with basic metabolism at the level of translation by an action that mimics that of the antibiotic hygromycin B (Liu et al., 2008) . The molecular mechanism behind this action remains unknown. Analytical studies suggested that the complex between Phd and Doc has a 2:1 stoichiometry (Gazit & Sauer, 1999b) . Evidence from CD spectroscopy suggests changes in secondary structure upon complex formation (Gazit & Sauer, 1999b) , in agreement with observations on other TA systems that the intrinsically flexible C-terminus of the antitoxin protein gets folded upon binding to the toxin (Loris et al., 2003; Kamada et al., 2003; Kamada & Hanaoka, 2005; Takagi et al., 2005; Mattison et al., 2006) . Here we report the crystallization of Doc and of the Phd:Doc complex from bacteriophage P1. 
Material and Methods

Expression and purification of Doc
H66Y
The biophysical parameters used for Doc, DocH66Y, Phd and Phd 52-73Se were derived from their primary sequence and are given in Table 1 . Oligonucleotides agDOC5a (CCCCATATGAGGCATATATCACCGGAAGAAC) and agDOC5d (CCCCTCGAGCGGATCCGCAGAACCATACAATC) were used to amplify docH66Y from a malEdocH66Y construct (Magnuson & Yarmolinsky, 1998) by PCR while at the same time introducing NdeI and XhoI restriction sites. After digesting this PCR product with NdeI and XhoI, the fragment containing the docH66Y gene was inserted in a pET21b vector (Novagen), which places a 6-His-tag at the C-terminus of docH66Y. E. coli 
Preparation of complexes
Wild-type Phd:Doc complex was purified according to (Gazit & Sauer, 1999b ). Phd 52-73Se , the C-terminal 22 amino acids of Phd in which seleno-methionine was substituted for Leu52 and Leu70 was obtained from Alta Bioscience (Birmingham, UK). The Doc H66Y :Phd 52-73Se complex was prepared by adding equimolar amounts of Phd 52-73Se to a concentrated Doc H66Y solution without further purification. Because of its low molar extinction coefficient, it was not possible to measure its concentration spectrophotometrically. Therefore, 1.0 mg of lyophilized powder (assumed to be pure) was weighted on a microbalance and dissolved directly in the solution containing Doc H66Y .
Crystallization
Crystallization conditions were screened at 293K with the hanging drop vapour diffusion method using the Hampton crystal screens 1 and 2 (Hampton Research, Riverside, CA, USA; Jancarik & Kim, 1991) . For crystallization experiments involving Doc H66Y , the protein was dialyzed against 20 mM TRIS/HCl, pH 8.0 and concentrated to 10 mg/ml. Concentrations were estimated spectrophotometrically at 280 nm using a theoretical molar extinction 4 coefficient of 7450 M -1 cm -1 calculated from the amino acid sequence (Gill & von Hippel, 1989) . The Doc H66Y :Phd 52-73Se complex was concentrated to 10 mg/ml in 20 mM TRIS/HCl, pH 7.5 (assuming a 1:1 stoichiometry corresponding to a calculated molar extinction coefficient of 8770 M -1 cm -1 ). The wild-type Phd:Doc complex was concentrated to 5 mg/ml in 50mM TRIS/HCl pH 7.4 (a 2:1 stoichiometry of Phd and Doc was assumed, corresponding with a theoretical molar extinction co-efficient of 8940 M -1 cm -1 for the complex). Drops consisting of 2 µl of protein solution and 2 µl of precipitant solution were equilibrated against 500 µl of the precipitant solution.
Promising conditions were further optimized by varying the precipitant concentration, temperature, pH and the ratio of protein to precipitant solution in the drops.
Seeding of Doc H66Y was done by diluting 1 µl of a drop containing small crystals into 50 µl of precipitant solution followed by vortexing and centrifugation (5 min at 13000 rpm in an Eppendorf centrifuge -approximately 100 g) to eliminate large pieces of crystals and retain only the nuclei. 1 µl of the supernatant was serially diluted into the precipitant solution consisting of 100 mM TRIS-HCl pH 8.0, 20% PEG 10000 (10 up to 10 8 times with the optimal dilution at 10 6 -10 7 ). 0.3 µl of these dilutions was used as additive in the crystallization setups (further consisting of 2 µl protein solution and 2 µl precipitant solution). The protein concentration was lowered to 5 mg/ml, a concentration for which we did not observe spontaneous nucleation within several weeks.
Data collection
A search for a suitable cryoprotectant solution for the Doc H66Y crystals was not successful. Crystals of Doc H66Y were therefore mounted in thin-walled glass capillaries and X-ray data were collected at room temperature on the EMBL beamline X13 of the DESY synchrotron (Hamburg, Germany) using a 165 mm MAR CCD detector.
Data for the Doc H66Y -Phd 52-73Se complex were collected on EMBL beamline X12 of the DESY synchrotron using a 225 mm MAR CCD detector. The crystals were flash-frozen directly in the cryostream after a short transfer (30 s -60 s) to a cryoprotectant solution consisting of 100mM TRIS/HCl, pH 8.5, 200mM NaCl, 1.5M NaBr and 35% MPD.
Crystals of the Phd:Doc complex were frozen directly in the cryostream without the need of adding an additional cryoprotectant. Data to 3.2 Å resolution were initially measured on EMBL beamline BW7B of the DESY synchrotron using a MAR345 image plate. Later on, higher resolution data were collected on the same crystal on beamline ID14-1 of the ESRF synchrotron (Grenoble, France) using an ADSC Quantum-4 detector (2 passes -2.9 and 2.4 Å resolution to compensate for overloads) and merged with the DESY data to compensate for loss of low resolution reflections due to overloads. Separating reflections along c* ultimately limited the useful resolution limit to 2.4 Å. The mosaicity of this crystal was 0.15°, much better than the typical 1.0° observed in other crystals of the Phd:Doc complex that were tested.
Because the long c-axis of these crystals runs perpendicular to the plane of the plate-shaped crystals, it was not possible to orient the Phd:Doc crystals with their c-axis parallel to the spindle axis (which would have both minimized spatial overlap and the rotation range necessary for obtaining a complete dataset). Therefore, prior to data collection, the crystal was oriented such that its c-axis was roughly perpendicular to the direct beam direction. From 5 this orientation, the crystal was rotated 55° back in Phi and subsequently 110° of data were collected. This strategy allowed us to avoid the crystal orientations with the most severe overlap problems while still obtaining an essentially complete dataset.
All data were indexed and integrated using DENZO and subsequent scaling and merging was done using SCALEPACK (Otwinowski & Minor, 1997) . Intensities were converted to structure factor amplitudes using the CCP4 program TRUNCATE and Matthews coefficients were calculated with the program MATTHEWS for cell content analysis (CCP4, 1994). The self-rotation function analysis was performed with MOLREP (Vagin & Teplyakov, 1997) .
For phasing, a crystal was soaked for about 3 minutes in a cryo-protecting solution (0.2 M NaCl, 0.1 M Sodium Acetate, pH 4.6 and 35% MPD) enriched with 1.5 M of NaBr. Data were collected at the K-edge of Br and processed using DENZO and SCALEPACK (Otwinowski & Minor, 1997) .. The heavy atom substructure was determined with SHELX-D (Sheldrick, 2008) and phasing subsequently proceeded with SHARP (de la Fortelle & Bricogne, 1997) as combined in the AutoRickshaw pipeline (Panjikar et al., 2005) .
Results and discussion
Because of problems in producing wild type Doc in large quantities, arising from the toxic nature of the protein (its action is to block protein synthesis by inhibiting the ribosome), we decided to use a less toxic variant His66Tyr (Magnuson & Yarmolinsky, 1998) . Size exclusion analysis of the mutant His66Tyr (Doc H66Y ) preparation that eluted from the Ni-NTA affinity column showed two peaks with apparent molecular weights corresponding to a dimer and a monomer. The ratio between monomer and dimer heavily depends on pH: the dimer is stable only at pH 8.0 and above (data not shown). Both forms were used for crystallization but crystals were obtained only for the dimer of Doc H66Y . Initial crystals of the Doc H66Y dimer were obtained in 20 % PEG10000, 100 mM TRIS/HCl, pH 8.0 ( Figure   2A ). These crystals were improved further by microseeding resulting in large single crystals ( Figure 2B ) suitable for X-ray diffraction experiments. They belong to space group P2 1 with unit cell dimensions a = 53.1 Å, b = 198.0 Å, c = 54.1 Å, β = 93.0°. They typically diffract to 2.5 Å resolution. The statistics for data collection are given in Table 2 .
Analysis of the unit cell content (Matthews, 1968) assuming the presence of discrete dimers suggests that the asymmetric unit contains between 3 to 5 such Doc H66Y dimers (V m values of 3.21, 2.40 and 1.92 for 3, 4 or 5 dimers in the a.u. corresponding to 62%, 49% and 36% solvent respectively). The κ=180° section of the self rotation function only shows two pronounced peaks distinct from the ones coresponding to the crystallographic symmetry operations. Analysis of the native Patterson also shows a pronounced non-origin peak at u = 0.473, v = 0.000, w = 0.499. Together this is consistent with two pairs of two dimers in the asymmetric unit, related to each other through a pure translational operation. This conclusion however, remains tentative until the structure will be determined. The best crystals diffracted to 1.9 Å resolution ( Figure 3A) . Statistics for data collection are given in Table 2 .
Crystals of the Doc
Calculation of Matthews coefficients (Matthews, 1968) indicates that the asymmetric unit most likely contains 2 Doc H66Y :Phd 52-73Se complexes (Vm = 1.92 Å 3 /Da corresponding to a solvent content of 35.9 % vs. Vm = 3.84 and 68% solvent for a single complex in the a.u.). Analysis of the self-rotation function did not reveal any significant peaks besides the ones expected from crystallographic symmetry.
After an initial phasing attempt using the seleno-methionines present in the Phd 52-73Se peptide failed (data not shown), a KBr soak was attempted. With data collected at the Br edge, a heavy atom substructure consisting of 17 potential bromide ions (or seleniums from the peptide) were identified with SHELX-D (Sheldrick, 2008) . Subsequent automatic phasing with the AUTORICKSHAW pipeline (Panjikar et al., 2005) resulted in an interpretable electron density map showing two complexes in the asymmetric unit. Refinement of this structure is ongoing.
Crystals of the Phd:Doc complex ( Figure 2D ) grow from 100 mM sodium acetate at pH 4.5, 20 mM CaCl 2 and 35-40% (v/v) MPD). These crystals appear after a few days and are shaped as halves of hexagonal plates ( Figure   2D ). The crystals belong to space group P3 1 21 or P3 2 21 with unit cell dimensions: a = b = 48.9 Å and c = 354.9 Å. A typical diffraction pattern is shown in Figure 3B . Although not diffracting on our home source, diffraction is systematically observed to at least 3.0 Å using synchrotron radiation and the best crystal diffracted to at least 2.4 Å at ESRF beamline ID14-1. Statistics for the best native data that could be collected until now are given in Table 2 . A Phd:Doc stoichiometry of 2:1 was previously reported for the isolated complex (Gazit & Sauer, 1999b) , but it is known that toxin-antitoxin complexes can have varying stoichiometries (Dao-Thi et al., 2002; Monti et al., 2007) .
Although SDS-PAGE analysis of the crystals indicates that both Doc and Phd are present in the crystals, it is difficult to pinpoint an exact stoichiometry and different ratios remain possible. Analysis of the self-rotation function of these crystals shows only pronounced peaks at κ = 180° and κ = 120° corresponding to the crystallographic symmetry axes, allowing no further conclusions to be drawn with respect to the entity present in the asymmetric unit. ( Figure   3E ) shows maxima corresponding only to crystallographic symmetry. The crystal structure of other TA complexes have shown toxin:antitoxin stoichiometries of 2:1 for MazEF (Kamada et al., 2003) , 1:1 for an archaeal RelBE and for a FitAB DNA complex (Takagi et al., 2005; Mattison et al., 2006) and 1:2 for YoeB/YefM (Kamada & Hanaoka, 2005 ).
In conclusion, we obtained well diffracting crystals for the components of the phd/doc toxin-antitoxin module.
Doc sequences show no evolutionary relationship with any other protein of known structure and its fold cannot be predicted. The crystal structures of Doc and the Phd:Doc complex are likely to shed further light on the molecular mode of action of Doc and the way it is regulated by Phd. 
